Materialise and U-M startup TRS announce partnership to manufacture 3D-printed tracheal splints

12/9/2015

Today, Materialise (NASDAQ: MTLS) and Tissue Regeneration Systems (TRS) announce a partnership to manufacture life-saving 3D-Printed tracheal splints for use in clinical trials…